Evolent Health Past Earnings Performance

Past criteria checks 0/6

Evolent Health has been growing earnings at an average annual rate of 24.8%, while the Healthcare Services industry saw earnings growing at 2.2% annually. Revenues have been growing at an average rate of 20.5% per year.

Key information

24.8%

Earnings growth rate

28.6%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate20.5%
Return on equity-9.1%
Net Margin-7.2%
Next Earnings Update09 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Evolent Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9EH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,964-1423060
30 Sep 231,790-1123070
30 Jun 231,632-772870
31 Mar 231,483-402630
31 Dec 221,352-192440
30 Sep 221,218-42430
30 Jun 221,088-192290
31 Mar 22990-242150
31 Dec 21908-302080
30 Sep 21906-451990
30 Jun 21923-681990
31 Mar 21918-2611970
31 Dec 20925-3281980
30 Sep 20915-5151960
30 Jun 20895-5042070
31 Mar 20870-3342280
31 Dec 19687-3042080
30 Sep 19803-1212480
30 Jun 19733-1072470
31 Mar 19685-862410
31 Dec 18627-532310
30 Sep 18548-492200
30 Jun 18506-492060
31 Mar 18468-561990
31 Dec 17435-611950
30 Sep 17409-651910
30 Jun 17362-641800
31 Mar 17311-551630
31 Dec 16254-1601480
30 Sep 16212-1461310
30 Jun 16192-1471220
31 Mar 161462201030
31 Dec 1597330710
30 Sep 1551322380
30 Jun 1510329130
31 Mar 150-37-10
31 Dec 140-3100
30 Sep 1413-2970
31 Dec 13262160

Quality Earnings: 9EH is currently unprofitable.

Growing Profit Margin: 9EH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9EH is unprofitable, but has reduced losses over the past 5 years at a rate of 24.8% per year.

Accelerating Growth: Unable to compare 9EH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9EH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-36.8%).


Return on Equity

High ROE: 9EH has a negative Return on Equity (-9.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.